Melissa E. Spann

Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale

David V. Sheehan, K. Harnett‐Sheehan, Melissa E. Spann et al. · International Clinical Psychopharmacology · 2010 · 122 citations

Psychotherapy, Psychological Co-morbidities, Mental Health +17

Duloxetine in the Prevention of Depressive Recurrences

David Pérahia, Giuseppe Maina, Michael E. Thase et al. · The Journal of Clinical Psychiatry · 2009 · 46 citations

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint

Mark H. Pollack, Susan G. Kornstein, Melissa E. Spann et al. · Journal of Psychiatric Research · 2008 · 38 citations

Psychopathology, Generalized Anxiety Disorder, Psychiatry +12

Sexual Function During Long-Term Duloxetine Treatment in Patients with Recurrent Major Depressive Disorder

Ángel L. Montejo, David Pérahia, Melissa E. Spann et al. · The Journal of Sexual Medicine · 2010 · 29 citations

The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: Results from three clinical trials

Katja Beesdo‐Baum, James T. Hartford, James Russell et al. · Journal of Anxiety Disorders · 2009 · 25 citations · Full text

Psychological Co-morbidities, Long-term Effect, Psychopathology +14